Tributyrin for Parkinson's with memory problems
Part of Brain & nervous system clinical trials.
This trial tests a supplement called tributyrin to see if it can help with thinking and memory problems in people with Parkinson's disease. You may be able to join if you have both Parkinson's and mild cognitive impairment or dementia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years old or older.
- You have Parkinson's disease and also have some memory or thinking problems (mild cognitive impairment or Parkinson's disease dementia).
- If you take certain medications for memory or mood, you have been on a steady dose for at least 4 weeks.
- You can have an MRI scan (no metal implants, pacemaker, or severe claustrophobia).
- You don't have other serious health issues like uncontrolled stomach disease, recent stroke, or suicidal thoughts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of brain stimulation called iTBS on an area of the brain that may help with thinking and memory problems in people with Parkinson's disease and mild cognitive impairment. If you qualify, you and your caregiver would take part in sessions and answer questions about your daily life.
This trial tests whether a type of noninvasive brain stimulation (tDCS) can improve thinking and memory in people with mild cognitive impairment in Parkinson’s disease. You may be eligible if you have these diagnoses, are on stable medications, and can safely complete brain scan/testing.
This trial tests if non-invasive brain stimulation can help with memory and thinking problems (mild cognitive impairment) in people with Parkinson's disease. It uses magnetic pulses and mild electrical current to stimulate the brain over a few weeks.
This study tests whether a thinking-and-memory training program (cognitive stimulation) can help people with Parkinson's who have mild memory or thinking problems, but not dementia. You must not have had deep brain stimulation surgery.
This Phase 2 study tests whether an added medication strategy can change brain targets linked to memory decline in people with Parkinson’s disease, including those with no memory problems or mild memory changes. It may help lower risk of developing dementia, but you must be able to safely do MRI scans and meet other health and medication rules.
This trial tests a supplement called tributyrin, which may help people with mild Alzheimer's by affecting the gut-brain connection. It aims to see if raising butyrate levels in the body can improve memory and thinking.
Hear when a new Parkinson Disease Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.